论文部分内容阅读
慢性阻塞性肺病最主要的并发症是慢性肺源性心脏病(肺心病)患病率为4.42‰,慢性肺心病心力衰竭治疗通常经氧疗、改善通气、抗炎、强心、利尿、纠正酸碱失衡和电解质紊乱等综合治疗多可使病情缓解,但部分患者仍达不到良好效果。我院1999年10月至2009年9月应用降纤酶治疗肺心病心力衰竭取得较为满意的疗效,现将其中有完整
The main complication of chronic obstructive pulmonary disease is the prevalence of chronic cor pulmonale (pulmonary heart disease) is 4.42 ‰, and treatment of chronic cor pulmonale heart failure usually by oxygen therapy, to improve ventilation, anti-inflammatory, cardiac, diuretic, correct Acid-base imbalance and electrolyte imbalance and other comprehensive treatment can make the condition eased, but some patients are still not up to good results. Our hospital from October 1999 to September 2009 application of defibrase in the treatment of heart failure of pulmonary heart disease to obtain more satisfactory results, now there is a complete